Abbott/Nihon Kohden partner in haematology:
This article was originally published in Clinica
Nihon Kohden and Abbott have entered into an agreement to commercialise automated haematology diagnostic instruments manufactured by Nihon Kohden of Tokyo, Japan. The products will be distributed exclusively by Abbott under the CELL-DYN Pearl brand name in the US and Canada. The Abbott Park, Illinois company also has non-exclusive distribution rights in all other markets apart from China and Japan. Harold Flynn, divisional vice-president and general manager of Abbott Hematology, said that the new agreement provided an opportunity to expand Abbott's instrument offering for smaller hospitals, large clinics and physician offices.
You may also be interested in...
Strong top-line efficacy in pyruvate kinase deficiency patients who don’t receive regular transfusions looks approvable, analysts say, but Agios will await data in regularly transfused patients.
ICON survey finds payers increasingly use ICER reports at multiple ‘touchpoints’ during the drug evaluation and decision-making process and the most common use reported in 2020 was as a reference in rebate and pricing negotiations.
Results of a forthcoming APhA survey showed about one-third cannot store Pfizer/BioNTech's BNT162b2, but can handle Moderna's mRNA-1273.